Pharmaceutical Executive
Genentech had previously been number one by a very wide margin. This year, that margin started to narrow. Novartis is now a much closer second
Peter Carlin
Advertisement
Articles by Peter Carlin
Advertisement
Latest Updated Articles
The Total Customer ExperienceJuly 1st 2008
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Enters $7.8 Billion Agreement to Acquire Centessa Pharmaceuticals to Advance Sleep-Wake Treatments
2
Novo Nordisk Launches Multi-Month Subscription Program for Wegovy
3
Merck Enters $838 Million Research & Development Collaboration with Infinimmune
4
Biogen Enters $5.6 Billion Agreement to Acquire Apellis Pharmaceuticals
5